Contact Us
Drug Search Results
More Filters [+]

Batefenterol

Alternative Names: batefenterol, gsk961081
Latest Update: 2023-07-01
Latest Update Note: PubMed Publication

Product Description

Batefenterol is a novel bifunctional molecule that combines muscarinic antagonism and beta2-agonism in a single molecule. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02570165)

Mechanisms of Action: MR Antagonist,ADRB2 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Inhalant,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Batefenterol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Chronic Obstructive Pulmonary Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Study 201012

P2

Completed

Chronic Obstructive Pulmonary Disease

2016-07-06

2015-001409-15

P2

Completed

Chronic Obstructive Pulmonary Disease

2016-07-06

NCT02573870

P2

Completed

Chronic Obstructive Pulmonary Disease

2016-07-05

NCT02663089

P1

Completed

Chronic Obstructive Pulmonary Disease

2016-03-17

53%

Recent News Events

Date

Type

Title

07/01/2023

PubMed

 Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach.

03/01/2022

News Article

 Terray Therapeutics Expands Leadership Team with Fez Ujjainwalla, PhD as Head of Business and Adam D. Hughes, PhD as Head of Chemistry

05/04/2020

PubMed

 A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions